On Demand: Engage with HeartX as an Evaluator or Pilot Site-Webinar Slides

Webinar Slides

Pdf Summary

The document introduces <strong>HeartX</strong>, a <strong>healthtech accelerator</strong> focused on bringing cardiovascular innovations—especially <strong>digital health, connected medical devices, and diagnostic platforms</strong>—into cardiology practices across the U.S. It emphasizes HeartX as a unique program that <strong>guarantees hospital pilot projects for early-stage companies</strong>, helping produce strong startup cohorts.

The presentation lists the <strong>HeartX leadership team</strong> from MedAxiom and HealthTech Arkansas and showcases prior cohorts from <strong>2022, 2023, 2024, and 2025</strong>. It highlights two example companies:

- <strong>MediWhale</strong> (Seoul, South Korea): Uses a <strong>1-minute retinal scan</strong> and AI to identify and predict cardiovascular disease risk. It is already cleared in Asia and Europe, is entering the U.S. market through HeartX, has launched a <strong>$7.5M Series A</strong>, and is embedded in heart screening programs in Arkansas.
- <strong>Caristo</strong> (Oxford, England): Uses AI to analyze <strong>coronary CT angiography (CCTA)</strong> scans to measure coronary inflammation and plaque. Its <strong>CaRi-Plaque</strong> technology has received <strong>FDA 510(k) clearance</strong>, and three HeartX sites have committed to a <strong>300-patient observational study</strong>.

The document also provides the <strong>2026 cohort timeline</strong>, including:
- Applications open: <strong>Feb 1 – Apr 30</strong>
- Pre-screen interviews: <strong>May 1 – Jun 13</strong>
- Secondary interviews: <strong>Jun 1 – Jul 1</strong>
- Internal deliberation: <strong>Jul 1 – Jul 15</strong>
- Finalize pilots and third interviews: <strong>Jul 15 – Aug 31</strong>
- Cohort selected and announced: <strong>Sep 3</strong>
- Kickoff: <strong>Oct 22 in Denver, CO</strong>

The process includes about <strong>100 applications</strong>, <strong>30 pre-screens</strong>, <strong>10–12 pitches</strong>, and <strong>5 selected pilots</strong>. Participation in trials is <strong>free to organizations</strong>, and HeartX supports startup, issue resolution, and closeout. Contact information is provided for those interested in serving as judges/evaluators or pilot sites.

Keywords

HeartX

healthtech accelerator

cardiovascular innovation

digital health

connected medical devices

diagnostic platforms

hospital pilot projects

MediWhale

Caristo

FDA 510(k) clearance